BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25591906)

  • 61. Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders.
    Carrà G; Nicolini G; Crocamo C; Lax A; Amidani F; Bartoli F; Castellano F; Chiorazzi A; Gamba G; Papagno C; Clerici M
    Nord J Psychiatry; 2017 Jul; 71(5):332-339. PubMed ID: 28635556
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Psychiatric comorbidity in a sample of cocaine-dependent outpatients seen in the Community of Madrid drug addiction care network.
    Martínez-Gras I; Ferre Navarrete F; Pascual Arriazu J; Peñas Pascual J; de Iceta Ruiz de Gauna M; Fraguas Herráez D; Rubio Valladolid G;
    Adicciones; 2016 Mar; 28(1):6-18. PubMed ID: 26990385
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mental health multimorbidity and poor quality of life in patients with schizophrenia.
    Bhalla IP; Stefanovics EA; Rosenheck RA
    Schizophr Res; 2018 Nov; 201():39-45. PubMed ID: 29709490
    [TBL] [Abstract][Full Text] [Related]  

  • 64. E-cigarette Use in Veterans Seeking Mental Health and/or Substance Use Services.
    Hefner K; Rosenheck R; Merrel J; Coffman M; Valentine G; Sofuoglu M
    J Dual Diagn; 2016; 12(2):109-17. PubMed ID: 27064443
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Service Use and Unmet Needs for Substance Use and Mental Disorders in Canada.
    Urbanoski K; Inglis D; Veldhuizen S
    Can J Psychiatry; 2017 Aug; 62(8):551-559. PubMed ID: 28616935
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
    Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Cougle JR; Hakes JK; Macatee RJ; Zvolensky MJ; Chavarria J
    J Clin Psychiatry; 2016 Apr; 77(4):e444-50. PubMed ID: 27137428
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Dual diagnosis in psychoactive substance abusing or dependent persons].
    Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT
    Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders?
    Zanis DA; McLellan AT; Corse S
    Community Ment Health J; 1997 Jun; 33(3):213-27. PubMed ID: 9211041
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders.
    Carrà G; Scioli R; Monti MC; Marinoni A
    Eur Addict Res; 2006; 12(2):96-101. PubMed ID: 16543745
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Absolute risk of suicide after first hospital contact in mental disorder.
    Nordentoft M; Mortensen PB; Pedersen CB
    Arch Gen Psychiatry; 2011 Oct; 68(10):1058-64. PubMed ID: 21969462
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Time patterns of attempted suicide.
    Valtonen H; Suominen K; Partonen T; Ostamo A; Lönnqvist J
    J Affect Disord; 2006 Feb; 90(2-3):201-7. PubMed ID: 16412521
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Specific major mental disorders and criminality: a 26-year prospective study of the 1966 northern Finland birth cohort.
    Tiihonen J; Isohanni M; Räsänen P; Koiranen M; Moring J
    Am J Psychiatry; 1997 Jun; 154(6):840-5. PubMed ID: 9167513
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevalence of co-occurring substance use and other mental disorders in the Canadian population.
    Rush B; Urbanoski K; Bassani D; Castel S; Wild TC; Strike C; Kimberley D; Somers J
    Can J Psychiatry; 2008 Dec; 53(12):800-9. PubMed ID: 19087478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serious mental illness among young adult women who use drugs in the club scene: co-occurring biopsychosocial factors.
    Lawental M; Surratt HL; Buttram ME; Kurtz SP
    Psychol Health Med; 2018 Jan; 23(1):82-88. PubMed ID: 28508675
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Personality in male patients with substance use disorder and/or severe mental illness.
    Fernández-Mondragón S; Adan A
    Psychiatry Res; 2015 Aug; 228(3):488-94. PubMed ID: 26144586
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.
    Dixon L
    Schizophr Res; 1999 Mar; 35 Suppl():S93-100. PubMed ID: 10190230
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015.
    Carrà G; Bartoli F; Riboldi I; Trotta G; Crocamo C
    Int J Soc Psychiatry; 2018 Nov; 64(7):656-659. PubMed ID: 30132359
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comorbid substance use disorder: prevalence, patterns of use, and course.
    Cuffel BJ
    New Dir Ment Health Serv; 1996; (70):93-105. PubMed ID: 8754233
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe.
    Carrà G; Johnson S; Crocamo C; Angermeyer MC; Brugha T; Azorin JM; Toumi M; Bebbington PE
    Psychiatry Res; 2016 May; 239():301-7. PubMed ID: 27046394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.